image credit- prnewswire
US-headquartered Advanced Sterilization Products (ASP) hasannounced that the STERRAD VELOCITY™ Biological Indicator (BI)/Process Challenge Device (PCD) 15-minute time to result will be commercially available in the Asia Pacific (APAC) region from 25 August 2021, particularly India, Japan, Thailand, Vietnam, South Korea and Singapore.
The STERRAD VELOCITY™ BI/PCD now provides a faster BI read time in 15 minutes, and with automated record-keeping and an intelligent, guided user interface, so that STERRAD™ System users can focus on protecting patients.
It is used to monitor loads and assess process performance for STERRAD™ Systems. This is a crucial step to verify load sterility for critical and semi-critical surgical instruments prior to releasing them to the operating room.
As the Asia Pacific counterpart of Advanced Sterilization Products (ASP), ASP APAC, based in Singapore, organizes regular educational webinars across the Asia Pacific region, featuring prominent speakers in the healthcare industry, focusing on a wide range of topics.
